Indeed, mice lacking Cdk2 are viable [65, 66] and targeted Cdk2 deletion in the pancreas induces glucose intolerance primarily by affecting glucose-stimulated insulin secretion [67]. The gene discussed is CDK2; the disease is Glucose intolerance.